Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK

Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK

Objectives: The verteporfin photodynamic therapy (VPDT) cohort study aimed to answer five questions: (a) Is VPDT in the NHS provided as in randomised trials?; (b) Is ‘outcome’ the same in the NHS as in randomised trials?; (c) Is ‘outcome’ the same for patients ineligible for randomised trials?; (d)...

Full description

Bibliographic Details
Main Authors: BC Reeves, SP Harding, J Langham, R Grieve, K Tomlin, J Walker, C Guerriero, J Carpenter, WP Patton, KA Muldrew, T Peto, U Chakravarthy
Format: Article
Language:English
Published: NIHR Journals Library 2012-02-01
Series:Health Technology Assessment
Subjects:
verteporfin photodynamic therapy
neovascular age-related macular degeneration
tap trial
cohort study
best-corrected distance visual acuity
Online Access:https://doi.org/10.3310/hta16060

Internet

https://doi.org/10.3310/hta16060

Similar Items